Ipratech SA
15.6 FTEIpratech reported total assets of €4.29m at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Oct 2026), with 15.6 full-time equivalents.
The score of Ipratech shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +25 % Total assets +106 % Headcount (avg FTE) +160 %
Accounts of the company itself (not consolidated).
The full file covers 18 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ipratech's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Oct 2026
- Year ended 31 Dec 2024filed on 29 Sep 2025
- Year ended 31 Dec 2023filed on 08 Jul 2024
- Year ended 31 Dec 2022filed on 07 Jul 2023
- Year ended 31 Dec 2021filed on 04 Jul 2022
Ipratech's financial analysis
- Solvency36.5%sector median: 57.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ipratech
Ipratech's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0893.778.586
- VAT number
- BE0893778586
- Peppol
- Registered · 0208:0893778586 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 28 Nov 2007
- Registered office
- 6041 Charleroi
- Size
- Small · 15.6 FTE
- Latest accounts
- 2025 · filed on 16 Oct 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Ipratech (SA) has been based in Charleroi since 2007, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 98,194 € and equity of €1.56m; its revenue is not published. With 15.6 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 36.5%, below the median of its sector (57.9%).
Companies similar to Ipratech
Companies in the same business, of comparable size and area, outside its group.
- Tanai Therapeutics Research and experimental development on natural sciences and engineering Ghent · balance sheet €3.87m
- ExeVir Bio Research and experimental development on natural sciences and engineering Ghent · balance sheet €3.76m
- Genflow Biosciences Research and experimental development on natural sciences and engineering Charleroi · balance sheet €3.74m
- XomeXBio Research and experimental development on natural sciences and engineering Charleroi · balance sheet €3.50m
- Wishbone Research and experimental development on natural sciences and engineering Flémalle · balance sheet €3.39m
- BIO-Sourcing Research and experimental development on natural sciences and engineering Liège · balance sheet €6.59m
- Amyl Therapeutics Research and experimental development on natural sciences and engineering Liège · balance sheet €7.02m
- Bioxodes Research and experimental development on natural sciences and engineering Charleroi · balance sheet €7.68m
Frequently asked questions about Ipratech
What is the revenue of Ipratech?
Ipratech files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ipratech?
In Belgium, the VAT number is the company number prefixed with BE: BE0893778586 for Ipratech, if the company is VAT-registered. Its company number (CBE) is 0893.778.586.
Where is the registered office of Ipratech?
According to the CBE register, the registered office of Ipratech is in 6041 Charleroi.
What is the equity of Ipratech?
At the close of the 2025 financial year, the equity of Ipratech amounts to 1,563,971 €, a solvency of 36.5% of total assets.
How many people work at Ipratech?
15.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Ipratech?
The register lists 6 active mandates at Ipratech. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ipratech
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →